The 21st UK Renal Registry Annual Report: A Summary of Analyses of Paediatric Data in 2017

Abstract

Children with end-stage kidney disease (ESKD) requiring renal replacement therapy (RRT) are usually managed in one of the 13 paediatric nephrology centres in the United Kingdom. The UK Renal Registry (UKRR) collects, analyses and reports data on children receiving RRT in these centres.<br/><br/>The UKRR annual report presents analyses relating to the attainment of the Renal Association audit measures [1], national averages to enable benchmarking and long-term trends for children on RRT for ESKD. Data are reported by centre to enable between centre comparisons.<br/><br/>To improve the timeliness of data reporting, the format of the UKRR 21st Annual Report, which included data to December 31, 2017 [2], differs significantly to that of previous years. For paediatric data, changes include a single chapter reporting demographic and biochemical data, reduced clinical commentary, a higher threshold for data quality control (with data completeness at least 70%) and greater alignment of analyses to the Renal Association guidelines [1].<br/><br/>In this article, we summarise the analyses of paediatric data presented in the UKRR 21st Annual Report. The corresponding adult summary is published separately in this issue. The full UKRR 21st Annual Report can be accessed at https://www.renalreg.org/reports/data_to_end_2017/.